Gujral told CNBC-TV18, "Midcap IT, midcap pharma is doing quite well and if people do need to trade these are the spaces. For Sasken Communication Rs 120 is a good support out here and Rs 165-170 is the next target because all of these places you don't have over ownership and these are good stocks to back once the market finds some sort of support."
Disclosure: It is safe to assume that analyst and his clients may have an investment interest in the above stock/sector.
